New California law mandates adherence to voluntary codes

Share this article:
A law slated to hit California law books July 1 is aimed at mandating pharma's compliance with two voluntary codes on marketing of prescription drugs.
California bill SB 1765 requires pharmaceutical companies to adopt a "Comprehensive Compliance Program" that is in accord with OIG's 2003 Compliance Program  Guidance, as well as PhRMA's Code of Interactions with Healthcare Professionals. Until now, adherence to either of these codes has not been mandatory.
Pharmas also must establish a limit on gifts or incentives provided to healthcare professionals, per the OIG and PhRMA guidelines.
Excluded from the gift requirement are drug samples, grants for continuing medical education and health education scholarships.
Finally, pharmas must annually declare their compliance with the new law in writing and make their compliance programs accessible online.
SB 1765, which also applies to some medical device companies, was signed by California Governor Arnold Schwarzenegger in September of last year. 
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.